Stock Price
6.11
Daily Change
0.10 1.58%
Monthly
8.63%
Yearly
9.21%
Q1 Forecast
5.60

MannKind reported $307.03M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Adma Biologics USD 236.62M 242K Dec/2024
Dynavax Technologies USD 117.23M 117.11M Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Halozyme Therapeutics USD 117.52M 98K Sep/2025
Insmed USD 212.58M 210.76M Sep/2025
MacroGenics USD 63.26M 62.63M Sep/2025
MannKind USD 307.03M 303.99M Sep/2025
Merck USD 2.49B 15.79M Sep/2025
Novo Nordisk DKK 4.44B 3.99B Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Xencor USD 71.34M 46K Sep/2025